Journal Club/Webinar

HomeMembersAssemblies and SectionsAssembliesRespiratory Structure and FunctionJournal Club/Webinar ▶ Technology Development: Translating Innovation from Bench to Bedside: Part 1, 2, 3 and 4
Technology Development: Translating Innovation from Bench to Bedside: Part 1, 2, 3 and 4

The ATS Assembly on Respiratory structure and Function, and the Drug/Device Discovery and Development Committee joint webinars.


Webinar date:
 April 30,2021

Technology Development: Translating Innovation from Bench to Bedside: Part 1

For many biomedical professionals, the process of taking a novel drug, device, or algorithm from research laboratory to market and the bedside feels like falling down a rabbit hole. This webinar is the first in a series designed to help participants understand and successfully navigate the necessary steps.

 

Co-chairs: 
Connie Hsia, MD, University of Texas Southwestern Medical Center, Dallas, TX
Heidi Mansour, PhD, RPh, The University of Arizona, Tucson, AZ

Speakers and Topics:

  1. "Overview, and Step 1: Getting a Patent".  Isamu Hartman, PhD, MBA, Office of Technology Commercialization, University of Texas Southwestern Medical Center, Dallas, TX

  2.  "Step 2: From Patent to Pilot Funding – Our Experience".  David Kaczka, MD, PhD, University of Iowa, Iowa City, IA
     
  3. “Resources at ATS for Drug/Device Discovery and Development”.  Courtney Crim, MD, University of North Carolina - Chapel Hill, NC 

Webinar date: September 24, 2021

Technology Development: Translating Innovation from Bench to Bedside: Part 2

For many biomedical professionals, the process of taking a novel drug, device, or software from research laboratory to the market and the bedside feels like falling down a rabbit hole. This webinar is the second installment in a series designed to help participants understand and successfully navigate the necessary steps.

Co-chairs:

Connie Hsia, MD, University of Texas Southwestern Medical Center, Dallas, TX

Heidi Mansour, PhD, RPh, The University of Arizona, Tucson, AZ

Speakers and Topics:

  1. "Pathway to SBIR / SRRT Funding: A Perspective from Academia". David Kaczka, MD, PhD, University of Iowa, Iowa City, IA
  1. "Identifying and Working with a Business Partner". Monica Hawley, PhD, COO OscillaVent, Inc., Iowa City, IA
  1. "REACH – an NIH Initiative to Commercialize Academic Assets". Reynold Panettieri, MD, Robert Wood Johnson Medical School, and the Rutgers Institute for Translational Medicine and Science, New Brunswick, NJ 

Webinar date:  April 6, 2022

Technology Development: Translating Innovation from Bench to Bedside: Part 3: Navigating Licensing and Start-ups

For many biomedical professionals, the process of taking a novel drug, device, or software from research laboratory to the market and the bedside feels like falling down a rabbit hole. This third installment of the webinar series is designed to help participants understand and successfully navigate the necessary steps. 

 
Co-chairs: 

Connie Hsia, MD, ATSF
University of Texas Southwestern Medical Center, Dallas, TX

Heidi Mansour, PhD, RPh, FAIMBE
Florida International University Center for Translational Science, Port St. Lucie, FL  

Speakers and Topics:  

  1. “An Academician’s Journey in Entrepreneurship: Opportunities and Pitfalls”. Amir A. Zeki, MD, University of California at Davis, Davis, CA

  2. “Identifying and Commercializing Innovative University-based Technology “. Ronald J. Shebuski, PhD, Patmos Therapeutics, Inc. 

Panelist: 

Rajagopal Gururajan, UC Davis InnovationAccess, Innovation and Technology Commercialization


Webinar Date: February 14, 2023

Technology Development: Translating Innovation from Bench to Bedside Part 4:  Advances in Digital Technology for Lung Health

 

For biomedical professionals, the process of taking a novel drug, device, or other products from the laboratory to market and bedside feels like falling down a rabbit hole while clinicians may find it challenging to keep abreast with technological advances for improving patient care.

 

Co-chairs: 

Connie Hsia, MD, ATSF, FCCP
University of Texas Southwestern Medical Center, Dallas, TX

Nina Patel, MD
Clinical Program Leader, Boehringer-Ingelheim, New York, NY

Speakers: 

“The Third Leg of the Stool: How Objective Wheeze/Cough Measures Can Help Improve Lung Health Outcomes”
Nick Delmonico, CEO & Founder, Mitchell Glass, MD, CMO
Strados Labs

"Real World Implementation of a Digital Health Platform for Asthma and COPD and the Promise it Holds". 
Meredith Barrett, VP, Population Health Research, ResMed, Inc.
Yury Rozenman, SVP, Business Development/Life Sciences, Propeller, Inc.